BioInvent, Bayer to extend development of therapeutic antibodies Pharmaceutical Business Review BioInvent's n-CoDeR libraries include over 20 billion (2 x 1010) highly diverse, fully human antibody fragments which have been created using the company's patented approach, generating antibodies with high affinity and selectivity. BioInvent CEO ... |
